Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Sharma

Showing results (421-430 of 464) with videos related to

Pageof 47
Sort By:
Clinical and Experimental Medicine|January 22, 2021
Lymphoma subtypes in India: a tertiary care center reviewSurabhi Jain, Moien Rasheed Lone, Ansh Goswami, et al.
Frontiers in Oncology|October 2, 2019
Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe AmplificationDeepshi Thakral, Gurvinder Kaur, Ritu Gupta, et al.
JCO Global Oncology|March 24, 2025
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From IndiaSneh Bhargave, Vinod Sharma, Babita Kataria, et al.
American Journal of Blood Research|March 20, 2023
Prognostic relevance of <i>NPM1, CEBPA,</i> and <i>FLT3</i> mutations in cytogenetically normal adult AML patientsAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2024
Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 ExpressionAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
JCO Global Oncology|May 13, 2022
Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in IndiaSudhir Kumar, Atul Sharma, Raja Pramanik, et al.
Ecancermedicalscience|December 3, 2025
Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH studyGhazal Tansir, Akhil Santhosh, Akash Kumar, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|June 23, 2012
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapesPasquale Niscola, Andrea Tendas, Luca Cupelli, et al.
American Journal of Blood Research|November 23, 2020
<i>MEF2C</i> expression, but not absence of bi-allelic deletion of TCR gamma chains (ABD), is a predictor of patient outcome in Indian T-acute lymphoblastic leukemiaJay Singh, Rajive Kumar, Deepak Verma, et al.
Journal of Cancer Research and Therapeutics|March 30, 2024
Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colonJayati Sarangi, Prasenjit Das, Aijaz Ahmad, et al.
Pageof 47

Showing results (421-430 of 464) with videos related to

Sort By:
Pageof 47
Clinical and Experimental Medicine|January 22, 2021
Lymphoma subtypes in India: a tertiary care center reviewSurabhi Jain, Moien Rasheed Lone, Ansh Goswami, et al.
Frontiers in Oncology|October 2, 2019
Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe AmplificationDeepshi Thakral, Gurvinder Kaur, Ritu Gupta, et al.
JCO Global Oncology|March 24, 2025
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From IndiaSneh Bhargave, Vinod Sharma, Babita Kataria, et al.
American Journal of Blood Research|March 20, 2023
Prognostic relevance of <i>NPM1, CEBPA,</i> and <i>FLT3</i> mutations in cytogenetically normal adult AML patientsAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2024
Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 ExpressionAparna Ningombam, Deepak Verma, Rajive Kumar, et al.
JCO Global Oncology|May 13, 2022
Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in IndiaSudhir Kumar, Atul Sharma, Raja Pramanik, et al.
Ecancermedicalscience|December 3, 2025
Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH studyGhazal Tansir, Akhil Santhosh, Akash Kumar, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|June 23, 2012
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapesPasquale Niscola, Andrea Tendas, Luca Cupelli, et al.
American Journal of Blood Research|November 23, 2020
<i>MEF2C</i> expression, but not absence of bi-allelic deletion of TCR gamma chains (ABD), is a predictor of patient outcome in Indian T-acute lymphoblastic leukemiaJay Singh, Rajive Kumar, Deepak Verma, et al.
Journal of Cancer Research and Therapeutics|March 30, 2024
Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colonJayati Sarangi, Prasenjit Das, Aijaz Ahmad, et al.
Pageof 47